BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29465024)

  • 1. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
    Bruno MT; Ferrara M; Fava V; Barrasso G; Panella MM
    Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
    Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L; Zhu Y; Bai Y; Zhang X; Ren C
    J Cancer Res Ther; 2017; 13(4):613-620. PubMed ID: 28901302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL).
    Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    Johansson H; Bjelkenkrantz K; Darlin L; Dilllner J; Forslund O
    PLoS One; 2015; 10(4):e0124460. PubMed ID: 25893988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 8. Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.
    Persson M; Elfström KM; Brismar Wendel S; Weiderpass E; Andersson S
    PLoS One; 2014; 9(2):e90023. PubMed ID: 24587193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
    Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X; Wang S; Wu X; Qiu X; Li F; Zeng Y; Chen Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D; Weiss G; Lack B; Chen V; Fusco J
    Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
    Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
    BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.
    Valença JE; Gonçalves AK; Guerreiro da Silva ID; Eleutério Junior J; Tenório da Silva T; Bruneska D; Ximenes RA
    Rev Bras Ginecol Obstet; 2016 Mar; 38(3):154-9. PubMed ID: 27022787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.